Sensitive ASX Announcement

Clarity expands supply of Cu-64 for Phase III trials

Published: 14/06/23, 08:51am (AEST)2 pages
Clarity Pharmaceuticals Ltd
CU6:ASXHealthcare

Recent CU6 Announcements

Price Sensitive only